- Mebutamate
-
Mebutamate Systematic (IUPAC) name 2-sec-Butyl-2-methylpropane-1,3-diyl dicarbamate Clinical data Pregnancy cat. ? Legal status Schedule IV (US) Identifiers CAS number 64-55-1 ATC code N05BC04 PubChem CID 6151 UNII 5H8F175RER KEGG D01807 ChEMBL CHEMBL1200922 Chemical data Formula C10H20N2O4 Mol. mass 232.277 g/mol (what is this?) (verify) Mebutamate[1] is a sedative and anxiolytic drug with anti-hypertensive (blood pressure lowering) effects. It has effects comparable to those of barbiturates such as secobarbital, but is only around 1/3 the potency of secobarbital as a sedative. Side effects include dizziness and headaches.[2]
References
- ^ The Merck Index (14 ed.). Merck Publishers. 5813. ISBN 978-0-911910-00-1.
- ^ Tetreault, L.; Richer, P.; Bordeleau, J. M. (1967). "Hypnotic properties of mebutamate: A comparative study of mebutamate, secobarbital and placebo in psychiatric patients". Canadian Medical Association journal 97 (8): 395–398. PMC 1923261. PMID 6037393. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=1923261.
This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it.